From: Analysis on evolution and research focus in psychiatry field
Sub-network | Number of document | Representative document | Cluster top term | Research focus |
---|---|---|---|---|
0 | 4 | Local cerebral glucose metabolic rates in obsessive-compulsive disorder | Obsessive-compulsive disorder | Obsessive-compulsive disorder |
1 | 30 | Research diagnostic criteria-rationale and reliability | Depression | Depression |
2 | 4 | Sex-differences in schizophrenia-timing or subtypes | Gender | Schizophrenia |
3 | 9 | National institute of mental health diagnostic interview schedule its history, characteristics and validity | Suicide attempt | Diagnosis of mental disorders |
4 | 5 | Social origins of depression-reply | Geriatric depression | Depression |
5 | 18 | The validity of DSM-III borderline personality disorder | Borderline personality-disorder | Diagnosis of mental disorders |
6 | 19 | Physiologic dysfunction of dorsolateral prefrontal cortex | Normal | Schizophrenia |
7 | 14 | Basal ganglia and limbic system pathology in schizophrenia-a morphometric study of brain volume and shrinkage | Schizophrenia | Schizophrenia |
8 | 12 | Family history method using diagnostic criteria reliability and validity | Schizophrenia | Schizophrenia |
9 | 6 | Protein measurement with the Folin Phenol Reagent | Prospect | Neurological biochemistry |
10 | 14 | Cerebral ventricular size and cognitive impairment in chronic schizophrenia | Ventricular enlargement | Schizophrenia |
11 | 22 | Diagnostic criteria for use in psychiatric research | Significance | Diagnosis of mental disorders |
12 | 25 | A rating scale for depression | Emotion | Diagnosis of mental disorders |
13 | 9 | Dexamethasone suppression test for melancholia | Depression | Depression |
14 | 5 | Bulimia treated with imipramine: a placebo –controlled, double-blind study | Serotonin connection | Neurological biochemistry |
15 | 18 | The brief psychiatric rating-scale | Seasonal affective-disorder | Diagnosis of mental disorder |
16 | 2 | Carbamazepin in manic –depressive illness: a new treatment | Dissociation | Drug treatment of mental disorders |
17 | 2 | Neuroleptic malignant syndrome | Neuroleptic malignant syndrome | Drug treatment of mental disorders |